Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-3-2
pubmed:abstractText
This study aimed to identify and evaluate molecular targets for the development of a novel combination chemotherapy to treat refractory and recurrent diffuse large B-cell lymphoma (DLBCL).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/7-hydroxystaurosporine, http://linkedlifedata.com/resource/pubmed/chemical/CDC2 Protein Kinase, http://linkedlifedata.com/resource/pubmed/chemical/CDC2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin B, http://linkedlifedata.com/resource/pubmed/chemical/MTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 70-kDa, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Staurosporine, http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/ribosomal protein S6 kinase, 70kD...
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1708-20
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19223503-Adult, pubmed-meshheading:19223503-Aged, pubmed-meshheading:19223503-Aged, 80 and over, pubmed-meshheading:19223503-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19223503-Apoptosis, pubmed-meshheading:19223503-Blotting, Western, pubmed-meshheading:19223503-CDC2 Protein Kinase, pubmed-meshheading:19223503-Cell Proliferation, pubmed-meshheading:19223503-Cyclin B, pubmed-meshheading:19223503-Drug Synergism, pubmed-meshheading:19223503-Female, pubmed-meshheading:19223503-Flow Cytometry, pubmed-meshheading:19223503-G1 Phase, pubmed-meshheading:19223503-Gene Expression Profiling, pubmed-meshheading:19223503-Humans, pubmed-meshheading:19223503-Immunoenzyme Techniques, pubmed-meshheading:19223503-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:19223503-Male, pubmed-meshheading:19223503-Middle Aged, pubmed-meshheading:19223503-Neoplasm Recurrence, Local, pubmed-meshheading:19223503-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:19223503-Phosphatidylinositol 3-Kinases, pubmed-meshheading:19223503-Phosphorylation, pubmed-meshheading:19223503-Protein Kinases, pubmed-meshheading:19223503-Proto-Oncogene Proteins c-akt, pubmed-meshheading:19223503-RNA, Messenger, pubmed-meshheading:19223503-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19223503-Ribosomal Protein S6 Kinases, 70-kDa, pubmed-meshheading:19223503-Sirolimus, pubmed-meshheading:19223503-Staurosporine, pubmed-meshheading:19223503-TOR Serine-Threonine Kinases, pubmed-meshheading:19223503-Tumor Cells, Cultured
pubmed:year
2009
pubmed:articleTitle
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
pubmed:affiliation
Department of Pathology, University of Maryland School of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't